Detalles de la búsqueda
1.
Drug Levels Associated With Optimal Discrimination Between Remission and Nonremission and Comparison of Antibody Assays During First Year of Stable Infliximab Maintenance Therapy in Inflammatory Bowel Disease.
Ther Drug Monit
; 44(2): 290-300, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34387220
2.
Therapeutic thresholds and mechanisms for primary non-response to infliximab in inflammatory bowel disease.
Scand J Gastroenterol
; 55(8): 884-890, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32631131
3.
Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure.
Ther Drug Monit
; 41(2): 235-242, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30883516
4.
Interactions Between Thiopurine Metabolites, Adalimumab, and Antibodies Against Adalimumab in Previously Infliximab-Treated Patients with Inflammatory Bowel Disease.
Dig Dis Sci
; 63(6): 1583-1591, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29564674
5.
Time Course and Clinical Implications of Development of Antibodies Against Adalimumab in Patients With Inflammatory Bowel Disease.
J Clin Gastroenterol
; 50(6): 483-9, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-26166141
6.
Systematic Information to Health-Care Professionals about Vaccination Guidelines Improves Adherence in Patients With Inflammatory Bowel Disease in Anti-TNFα Therapy.
Am J Gastroenterol
; 110(11): 1526-32, 2015 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26032156
7.
Individualized Therapy Is a Long-Term Cost-Effective Method Compared to Dose Intensification in Crohn's Disease Patients Failing Infliximab.
Dig Dis Sci
; 60(9): 2762-70, 2015 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-25673037
8.
Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease: post hoc analysis of a randomized controlled trial.
Am J Gastroenterol
; 109(7): 1055-64, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24796769
9.
Comparison of techniques for monitoring infliximab and antibodies against infliximab in Crohn's disease.
Ther Drug Monit
; 35(4): 530-8, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23765033
10.
Infliximab clearance decreases in the second and third trimesters of pregnancy in inflammatory bowel disease.
United European Gastroenterol J
; 9(1): 91-101, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079627
11.
Long-term effects and colectomy rates in ulcerative colitis patients treated with infliximab: a Danish single center experience.
Scand J Gastroenterol
; 45(12): 1457-63, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20701434
12.
[Approval of new medicinal products - administrative procedures].
Ugeskr Laeger
; 181(21)2019 May 20.
Artículo
en Da
| MEDLINE | ID: mdl-31124440
13.
[Approval of new medicinal products - documentation requirements].
Ugeskr Laeger
; 181(21)2019 May 20.
Artículo
en Da
| MEDLINE | ID: mdl-31124441
14.
Tumor necrosis factor-alpha binding capacity and anti-infliximab antibodies measured by fluid-phase radioimmunoassays as predictors of clinical efficacy of infliximab in Crohn's disease.
Am J Gastroenterol
; 103(4): 944-8, 2008 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-18028512
15.
How to Minimize Placebo Response and Remission Rates.
Inflamm Bowel Dis
; 29(9): 1508-1509, 2023 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36426807
16.
A Role for Thiopurine Metabolites in the Synergism Between Thiopurines and Infliximab in Inflammatory Bowel Disease.
J Crohns Colitis
; 12(3): 298-305, 2018 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29145599
17.
Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
Inflamm Bowel Dis
; 23(7): 1210-1217, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28445244
18.
Magnitude of Increased Infliximab Clearance Imposed by Anti-infliximab Antibodies in Crohn's Disease Is Determined by Their Concentration.
AAPS J
; 19(1): 223-233, 2017 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27739011
19.
Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.
Inflamm Bowel Dis
; 22(8): 1999-2015, 2016 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27135483
20.
Circulating Cytokines and Cytokine Receptors in Infliximab Treatment Failure Due to TNF-α Independent Crohn Disease.
Medicine (Baltimore)
; 95(16): e3417, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-27100432